National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 11/06/2008



Introduction






Overview






Description and Causes






Prevention and Treatment of Oral Complications Before Chemotherapy and/or Radiation Therapy Begins






Management of Oral Complications During and After Chemotherapy and/or Radiation Therapy






Management of Oral Complications of High-Dose Chemotherapy and/or Stem Cell Transplant






Relapse and Second Cancers






Oral Complications Not Related to Chemotherapy or Radiation Therapy






Mental and Social Considerations






Special Considerations for Children






Get More Information From NCI






Changes to This Summary (11/06/2008)






Questions or Comments About This Summary






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Management of Oral Complications of High-Dose Chemotherapy and/or Stem Cell Transplant

Patients who have received transplants are at risk of graft-versus-host disease.

Graft-versus-host disease (GVHD) is a reaction of donated bone marrow or stem cells against the patient's tissue. Symptoms of oral GVHD include the following:

  • Sores that appear in the mouth 2 to 3 weeks after the transplant.
  • Dry mouth.
  • Pain from spices, alcohol, or flavoring (such as mint in toothpaste).

Biopsies taken from the lining of the mouth and salivary glands may be needed to diagnose oral GVHD. Treatment of oral GVHD may include the following:

Dentures, braces, and oral appliances require special care during high-dose chemotherapy and/or stem cell transplant.

The following are guidelines for the care and use of dentures, braces, and other oral appliances during high-dose chemotherapy and/or stem cell transplant:

  • Remove brackets, wires, and retainers before high-dose chemotherapy begins.


  • Wear dentures only when eating during the first 3 to 4 weeks after the transplant.


  • Brush dentures twice a day and rinse them well.


  • Soak dentures in an antibacterial solution when they are not being worn.


  • Clean denture soaking cups and change denture soaking solution every day.


  • Remove appliances or dentures when cleaning the mouth.


  • If mouth sores are present, avoid wearing removable appliances until the mouth is healed.


Dental treatments may be resumed when the transplant patient's immune system returns to normal.

Routine dental treatments, including scaling and polishing, should be delayed until the transplant patient's immune system returns to normal. Caution is advised for at least a year after the transplant.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov